AMBEV S.A. current report, Q3 FY2014

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. reports on a Board of Directors meeting held on September 17, 2014, in São Paulo, Brazil. The document serves as an extract of the minutes detailing corporate governance actions rather than a periodic financial report.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the period ending September 30, 2014. The only financial data disclosed relates to a specific capital transaction:

  • Capital Increase Amount: R$ 18,129,871.22
  • New Shares Issued: 4,991,736 common shares
  • Issuance Price: R$ 3.631977 per share
  • Updated Total Capital: R$ 57,508,839,341.45
  • Updated Total Shares Outstanding: 15,699,508,401 common shares

Material Changes

The primary material change reported is the ratification of a capital increase resulting from the exercise of stock options by certain beneficiaries. This action increased the company's authorized capital and total share count without preemptive rights, in accordance with the Company's Stock Option Plan and Brazilian corporate law.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or details on unusual items. The document is strictly limited to the procedural approval of the stock option exercise and the resulting capital structure adjustment.

Investor Verification Checklist

  • Verify the impact of the 4,991,736 new shares on existing shareholder dilution.
  • Confirm the updated total share count of 15,699,508,401 in subsequent filings.
  • Review the Company's Stock Option Plan rules to understand the vesting and exercise conditions for future grants.
  • Note that this filing contains no operational or financial performance data for Q3 2014.